WallStreetZenWallStreetZen

NASDAQ: ANIK
Anika Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ANIK

Based on 1 analyst offering 12 month price targets for Anika Therapeutics Inc

Min Forecast
$17.00+12.43%
Avg Forecast
$17.00+12.43%
Max Forecast
$17.00+12.43%

Should I buy or sell ANIK stock?

Based on 1 analyst offering ratings for Anika Therapeutics Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their ANIK stock forecasts and price targets.

ANIK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-27

1 of 1

Forecast return on equity

Is ANIK forecast to generate an efficient return?

Company
6.69%
Industry
18.7%
Market
150.4%
ANIK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANIK forecast to generate an efficient return on assets?

Company
4.99%
Industry
12.56%
ANIK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANIK earnings per share forecast

What is ANIK's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.12
Avg 2 year Forecast
$0.16
Avg 3 year Forecast
$0.67

ANIK revenue forecast

What is ANIK's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$121.0M+4.06%
Avg 2 year Forecast
$129.1M+11.05%
Avg 3 year Forecast
$136.3M+17.22%
ANIK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ANIK revenue growth forecast

How is ANIK forecast to perform vs Medical Devices companies and vs the US market?

Company
5.26%
Industry
9.02%
Market
16.85%
ANIK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ANIK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ANIK vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ANIK$15.12$17.00+12.43%Buy
INGN$7.11$12.00+68.78%Strong Buy
LUCD$1.08$4.83+347.50%Strong Buy
ELMD$25.94$36.00+38.78%Strong Buy
CVRX$7.07$10.00+41.44%Strong Buy
View Top Medical Device Stocks

Anika Therapeutics Stock Forecast FAQ

Is Anika Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ANIK) stock is to Buy ANIK stock.

Out of 1 analyst, 0 (0%) are recommending ANIK as a Strong Buy, 1 (100%) are recommending ANIK as a Buy, 0 (0%) are recommending ANIK as a Hold, 0 (0%) are recommending ANIK as a Sell, and 0 (0%) are recommending ANIK as a Strong Sell.

If you're new to stock investing, here's how to buy Anika Therapeutics stock.

What is ANIK's earnings growth forecast for 2026-2028?

(NASDAQ: ANIK) Anika Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 31%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 67.68%.

Anika Therapeutics's earnings in 2026 is -$11,063,000.On average, 4 Wall Street analysts forecast ANIK's earnings for 2026 to be -$1,628,608, with the lowest ANIK earnings forecast at -$8,475,682, and the highest ANIK earnings forecast at $5,728,071. On average, 4 Wall Street analysts forecast ANIK's earnings for 2027 to be $2,103,619, with the lowest ANIK earnings forecast at -$1,955,927, and the highest ANIK earnings forecast at $6,426,616.

In 2028, ANIK is forecast to generate $8,957,346 in earnings, with the lowest earnings forecast at $8,606,078 and the highest earnings forecast at $9,220,797.

What is ANIK's revenue growth forecast for 2026-2028?

(NASDAQ: ANIK) Anika Therapeutics's forecast annual revenue growth rate of 5.26% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.85%.

Anika Therapeutics's revenue in 2026 is $116,263,000.On average, 4 Wall Street analysts forecast ANIK's revenue for 2026 to be $1,609,714,392, with the lowest ANIK revenue forecast at $1,545,182,115, and the highest ANIK revenue forecast at $1,658,679,088. On average, 4 Wall Street analysts forecast ANIK's revenue for 2027 to be $1,717,889,115, with the lowest ANIK revenue forecast at $1,637,257,033, and the highest ANIK revenue forecast at $1,782,687,504.

In 2028, ANIK is forecast to generate $1,813,290,439 in revenue, with the lowest revenue forecast at $1,742,238,407 and the highest revenue forecast at $1,866,645,991.

What is ANIK's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: ANIK) forecast ROA is 4.99%, which is lower than the forecast US Medical Devices industry average of 12.56%.

What is ANIK's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ANIK price target, the average ANIK price target is $17.00, with the highest ANIK stock price forecast at $17.00 and the lowest ANIK stock price forecast at $17.00.

The Wall Street analyst predicted that Anika Therapeutics's share price could reach $17.00 by Feb 27, 2027. The average Anika Therapeutics stock price prediction forecasts a potential upside of 12.43% from the current ANIK share price of $15.12.

What is ANIK's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ANIK) Anika Therapeutics's current Earnings Per Share (EPS) is -$0.79. On average, analysts forecast that ANIK's EPS will be -$0.12 for 2026, with the lowest EPS forecast at -$0.64, and the highest EPS forecast at $0.43. On average, analysts forecast that ANIK's EPS will be $0.16 for 2027, with the lowest EPS forecast at -$0.15, and the highest EPS forecast at $0.48. In 2028, ANIK's EPS is forecast to hit $0.67 (min: $0.65, max: $0.69).

What is ANIK's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: ANIK) forecast ROE is 6.69%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.